Turki Al-Hussain

Turki Al-Hussain

Auto-generated profile, based on publicly available information

Turki Al-Hussain

Department of Pathology and Laboratory Medicine King Faisal Specialist Hospital and Research Centre Riyadh Saudi Arabia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2024 in Histopathology
Verified
Journal Article
Closed access
TATurki Al‐Hussain
Turki Al‐Hussain
WBWalaa Borhan
Walaa Borhan


31 July 2021 in Cureus
Verified
Journal Article
Open access
MAMohammad Alghafees
Mohammad Alghafees
RSRaouf M. Seyam
Raouf M. Seyam
WAWaleed M. Altaweel
Waleed M. Altaweel
OAOmar S. Alghamdi
Omar S. Alghamdi
TATurki Al-Hussain
Turki Al-Hussain
LALaila Alessa
Laila Alessa
The bulbar urethra is the most common site of anterior urethral strictures. In this case report, we present a 30-year-old male who was referred to us as a case of mid-bulbar urethral stricture. Urethroplasty was booked and a papillary lesion was found on routine diagnostic cystoscopy. An open biopsy was taken which showed invasive high-grade papillary urothelial carcinoma with squamous differentiation. This case is rare in terms of a young age of incidence, a lack of risk factors, an absence of suspicious symptoms, and a short duration of signs and symptoms. Urologists should consider workup for malignancy even in young patients who present with an idiopathic urethral stricture and a short duration of symptoms.

25 June 2026 in International Journal of Surgical Pathology
Verified
Journal Article
Closed access
MBMuhammad Abrar Barakzai
Muhammad Abrar Barakzai
SAShoukat Ali Arain
Shoukat Ali Arain
NANasir Ali Afsar
Nasir Ali Afsar
YAYara Obaeda Alsouss
Yara Obaeda Alsouss
TATurki Al-Hussain
Turki Al-Hussain
Background: This study assessed the potential utility of GATA3, cyclin D1, KRT20, and GLUT1 immunohistochemistry (IHC) markers for diagnosing renal epithelial tumors. Methods: A retrospective analysis was conducted on all eligible specimens ( n = 95) diagnosed at our institution between 2014 and 2024. IHC was done and the staining intensity and distribution of selected IHC markers were assessed. Results: Among 95 specimens, 26% were clear cell renal cell carcinoma, 21% were chromophobe RCC, and 17% were papillary RCC. Less frequent subtypes included TFE3-rearranged RCC, clear cell papillary renal cell tumor (CCPRT), papillary renal neoplasm with reverse polarity (PRNRP), and eosinophilic solid and cystic RCC (ESC-RCC). Clear cell RCC and CCPRT were consistently positive for cyclin D1 and GLUT1, and negative for GATA3/KRT20. CCPRT showed strong, diffuse GLUT1, unlike the limited staining in papillary RCC. PRNRP was positive for GATA3, cyclin D1, and GLUT1, and negative for KRT20. While chromophobe RCC exhibited variable GATA3 and GLUT1 expression with weak to moderate cyclin D1 positivity, oncocytomas were strong cyclin D1 positive, with negative GATA3, KRT20, and GLUT1. All 3 ESC-RCC specimens were KRT20 positive. Conclusions: Our findings validate many previously reported observations and characterize adjunctive patterns of these less commonly used markers across renal tumor subtypes. It suggests GATA3 as a potential diagnostic tool for PRNRP, while GLUT1 demonstrates differential expression patterns for papillary RCC and CCPRT, aiding in distinguishing papillary renal tumors. Similarly, cyclin D1 appears to be a valuable adjunct in differentiating oncocytoma from chromophobe RCC. Also, KRT20 shows high specificity for ESC-RCC.